AQUAVAC® RELERA™

Species

Diseases Treated

Country

Environment

AQUAVAC® RELERA™



Inactivated, vaccine against Enteric Redmouth Disease (ERM) caused by Yersinia ruckeri biotype 1 and biotype 2 (Hagerman type 1 and EX5 biogroup) in rainbow trout (Oncorhynchus mykiss).

Key Features

  • Protection for small fry: AquaVac RELERA can be administered by immersion vaccination to trout fry from 5g.

  • Contains strains of the EX5 biogroup (biotype 2) as well as Hagerman type 1 (biotype 1), thereby providing protection against the emerging disease as well as classical ERM.

  • Part of disease control program for the most common disease in farmed trout.

  • Registered for use as a booster injection vaccine in trout as small as 12g. 

  • Excellent safety profile.

  • Available in all rainbow trout producing countries in Europe. 

 

Key Benefits

  • Increased survival in fry and juvenile rainbow trout.

  • Increased protection against biotype 2 strains of Yersinia ruckeri which have been shown to be an increasing problem throughout Europe. 

  • Safe and easy to use in fry of 5g.

  • Forms part of a Total Protection Strategy against Enteric Redmouth Disease.

AQUAVAC® and RELERA™ are the property of Intervet International B.V. or affiliated companies or licensors and is protected by copyrights, trademark and other intellectual property laws.

NOTE: Specific product details of indications, registration license status, and trademarks, etc. may vary from country to country. Users should check the license status, local label and/or data sheet for exact specifications of usage or contact the local Intervet/Schering-Plough Animal Health representative